FOXC2 and breast carcinoma: This reduction leads to the upregulation of Yes-associated protein 1/WW-domain-containing transcription regulator 1 (YAP/TAZ) and subsequently enhances the transcriptional activity of associated domain (TEAD1-4) and the forkhead box C2 (FOXC2), which regulate the expression of GLUT3 and lncRNA breast cancer anti-estrogen resistance 4 (BCAR4) [162, 163].